Search - tctmd.com

Displaying 261 - 280 of 553

Sort: Relevancy | Date

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Todd Neale

March 08, 2021

News Daily News

Prostate Cancer Treatment Heightens Arrhythmia Risk

Todd Neale

February 23, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Michael O'Riordan

February 01, 2021

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Todd Neale

February 01, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Shelley Wood

November 17, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

Advertisement

April 2021 News Roundup

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Roughly 80% of ESC Guideline Writers Have Financial COIs

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Prostate Cancer Treatment Heightens Arrhythmia Risk

FDA Approves Evinacumab for Rare Homozygous FH

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 2021 News Roundup

Review Spotlights SCAD Diagnosis and Treatment

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Even Low-Dose Steroids Increase the Risk of CVD

Colchicine in the Crosshairs for Its High US Cost

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content